Open-label Randomized Controlled Trial of Controlled-release Formulation Budesonide in Indian Proteinuric IgA Nephropathy Patients
Introduction: IgA nephropathy (IgAN) in India is reported to have an onset at a younger age with faster progression to kidney failure requiring replacement therapy, where safe immunosuppression may improve the outcome. The gut-renal connection and multihit pathogenesis of IgAN targeted by an oral ta...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2026-03-01
|
| Serier: | Kidney Medicine |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S259005952500202X |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|